96-1741. Oral Dosage Form New Animal Drugs; Oxytetracycline Hydrochloride Soluble Powder  

  • [Federal Register Volume 61, Number 20 (Tuesday, January 30, 1996)]
    [Rules and Regulations]
    [Pages 2914-2915]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-1741]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 520
    
    
    Oral Dosage Form New Animal Drugs; Oxytetracycline Hydrochloride 
    Soluble Powder
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulations to reflect approval of an abbreviated new animal drug 
    application (ANADA) filed by Phoenix Scientific, Inc. The ANADA 
    provides for the use of a generic oxytetracycline hydrochloride soluble 
    powder administered orally in drinking water for either control or 
    control and treatment of certain diseases of chickens, turkeys, swine, 
    cattle, and sheep.
    
    EFFECTIVE DATE: January 30, 1996.
    
    FOR FURTHER INFORMATION CONTACT: Melanie R. Berson, Center for 
    Veterinary Medicine (HFV-135), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-594-1643.
    
    SUPPLEMENTARY INFORMATION: Phoenix Scientific, Inc., 3915 South 48th 
    St. Ter., P.O. Box 6457, St. Joseph, MO 64506-0457, filed ANADA 200-146 
    which provides for use of oxytetracycline hydrochloride soluble powder 
    in the drinking water of chickens, turkeys, swine, cattle, and sheep. 
    The medicated drinking water is used as follows: (1) Chickens for 
    control of infectious synovitis caused by Mycoplasma synoviae, chronic 
    respiratory disease and air sac infections caused by Mycoplasma 
    gallisepticum and Escherichia coli, and fowl cholera caused by 
    Pasteurella multocida; (2) turkeys for control of hexamitiasis caused 
    by Hexamita meleagridis, infectious synovitis caused by M. synoviae, 
    and complicating bacterial organisms associated with blue comb 
    (transmissible enteritis; coronaviral enteritis); (3) swine for control 
    and treatment of bacterial enteritis caused by E. coli and Salmonella 
    choleraesuis and bacterial pneumonia caused by P. multocida; (4) 
    breeding swine for control and treatment of leptospirosis (reducing the 
    incidence of abortions and shedding of leptospira) caused by Leptospira 
    pomona; (5) calves, beef cattle, and nonlactating dairy cattle for 
    control and treatment of bacterial enteritis caused by E. coli and 
    bacterial pneumonia (shipping fever complex) caused by P. multocida; 
    and (6) sheep for control and treatment of bacterial enteritis caused 
    by E. coli and bacterial pneumonia (shipping fever complex) caused by 
    P. multocida.
    
        - ANADA 200-146 for Phoenix Scientific's oxytetracycline 
    hydrochloride soluble powder is approved as a generic copy of Pfizer's 
    Terramycin Soluble Powder which is covered by NADA 8-622. The 
    ANADA is approved as of December 7, 1995, and the regulations in 21 CFR 
    520.1660d are amended to reflect the approval. The basis for approval 
    is discussed in the freedom of information summary.
        In accordance with the freedom of information provisions of part 20 
    (21 CFR part 20) and Sec. 514.11(e)(2)(ii) (21 CFR 514.11(e)(2)(ii)), a 
    summary of safety and effectiveness data and information submitted to 
    support approval of this application may be seen in the Dockets 
    Management Branch (HFA-305), Food and Drug Administration, rm. 1-23, 
    12420 Parklawn Dr., Rockville, MD 20857, between 9 a.m. and 4 p.m., 
    Monday through Friday.
        The agency has determined under 21 CFR 25.24(d)(1)(i) that this 
    action is of a type that does not individually or cumulatively have a 
    significant effect on the human environment. Therefore, neither an 
    environmental assessment nor an environmental impact statement is 
    required.
    
    List of Subjects in 21 CFR Part 520
    
        -Animal drugs.
        
    [[Page 2915]]
    
        -Therefore, under the Federal Food, Drug, and Cosmetic Act and 
    under authority delegated to the Commissioner of Food and Drugs and 
    redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is 
    amended as follows:
    
    PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
    
        -1. The authority citation for 21 CFR part 520 continues to read as 
    follows:
    
        -Authority: Sec. 512 of the Federal Food, Drug, and Cosmetic Act 
    (21 U.S.C. 360b).
    
        -2. Section 520.1660d is amended by adding new paragraphs (a)(7) 
    and (b)(5) to read as follows:
    
    
    Sec.  520.1660d Oxytetracycline hydrochloride soluble powder.
    
        -(a) * * *
        -(7) Each 18.14 grams of powder contains 1 gram of OTC HCl (pail: 2 
    lb).
        -(b) * * *
        -(5) No. 059130 for use of OTC HCl concentration in paragraph 
    (a)(7) of this section in chickens, turkeys, swine, cattle, and sheep.
    * * * * * -
    
        Dated: January 3, 1996.
    Stephen F. Sundlof,
    Director, Center for Veterinary Medicine.
    [FR Doc. 96-1741 Filed 1-29-96; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Effective Date:
1/30/1996
Published:
01/30/1996
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
96-1741
Dates:
January 30, 1996.
Pages:
2914-2915 (2 pages)
PDF File:
96-1741.pdf
CFR: (1)
21 CFR 520.1660d